A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167
This study, called "A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167," is in its very first stage and is open to healthy adults. The main goal is to find out the most effective and comfortable way to inject a new medication called COR-1167 under the skin. Researchers want to understand things like how quickly it gets into the body and how well it's tolerated with different injection methods. This particular study isn't treating chronic heart failure directly; instead, it's gathering important information that will help in future studies of COR-1167 for people who do have chronic heart failure. By finding the best way to give the medication, they hope to make potential future treatments for heart failure more effective and user-friendly for patients.
At a glance
What is this study about?
Imagine you need a new medicine, but no one knows the very best way to give it to you – should it be a slow injection or a quick one? A big shot or a small one? This study, looking at a medicine called COR-1167, is trying to answer exactly those questions for an injection that goes just under the skin. It's the very first step in exploring this new medicine.
Even though COR-1167 might eventually be used for people with a serious condition called chronic heart failure, this particular study isn't for them. Instead, it's looking for healthy people to take part. This is really common in early drug development. By studying healthy volunteers, researchers can safely learn how the body processes the new medicine and how different injection methods work, without the added complications of having a heart condition.
The information gathered from healthy volunteers is incredibly important. It helps scientists understand the basics of how the drug behaves in the body, such as how much gets into the bloodstream and how long it stays there. This foundational knowledge will then guide future, larger studies that will look at whether COR-1167 is safe and effective for people living with chronic heart failure. Ultimately, the goal is to develop better, more convenient ways to deliver treatments for this condition.
Key takeaways
- This is an early-stage study (Phase 1) looking at a new medicine called COR-1167.
- It aims to find the best way to give COR-1167 by injection under the skin.
- The study is for healthy adult volunteers, not people with heart failure.
- Information from this study will help develop future treatments for chronic heart failure.
- Your health will be carefully monitored throughout your participation.
Who may be eligible?
This study is specifically looking for healthy adults. You need to be at least 18 years old to take part, and there's no upper age limit set, so older adults can also participate if they are healthy enough.
To be considered healthy, generally, this means you don't have any major ongoing medical conditions that require regular treatment or would affect how your body handles the study medication. Both men and women are welcome to join.
Because this is an early-stage study for a new medication, there will be very strict health checks to make sure it's safe for you to participate. You would have a thorough medical assessment before being allowed to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself generally healthy?
- Do you not have a diagnosis of chronic heart failure?
- Are you able to attend several clinic visits for assessments and injections?
- Are you comfortable with blood tests and injections?
What does participation involve?
If you decide to take part in this study, you would likely have several visits to a clinic. These visits are important for researchers to check your health, give you the study medication (COR-1167) through an injection under your skin, and then monitor how your body reacts. They will probably take blood samples at different times to see how the medication is absorbed and processed by your body. You might also have other tests, like checking your heart rate or blood pressure.
The study involves trying out different ways of giving the injection, so you might receive the medication in various ways over the course of your participation. There will be follow-up appointments to ensure you are feeling well and to collect any final information. The overall length of your involvement in the study will be explained in detail by the study team, including how long each visit might last and the total duration of your participation, from your first visit to your last follow-up.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What is chronic heart failure?
Chronic heart failure is a long-term condition where the heart can't pump enough blood around the body. It can cause symptoms like breathlessness and tiredness.
Why are healthy people needed for this study?
Healthy people are needed in early studies to safely learn how the new medication works in the body and to find the best way to give it, before it's tested in people with the actual condition.
Will I receive treatment for heart failure in this study?
No, this study is not treating heart failure. It is designed to understand how a new medication is given and processed by the body in healthy volunteers.
What does 'subcutaneous injection' mean?
A subcutaneous injection is a needle jab that goes just under the skin, for example, as you might give yourself insulin.
Will I get paid for taking part?
Some studies offer compensation for your time and travel, but you would need to ask the study team directly if this study does.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.